Preferred Name |
Misoprostol |
|
Synonyms |
Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)- |
|
Definitions |
A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties. |
|
ID |
http://purl.bioontology.org/ontology/MESH/D016595 |
|
altLabel |
Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)- SC29333 Misoprostol, (11beta,13E,16S)-Isomer Novo Misoprostol Glefos Apo Misoprostol SC-30249 Apo-Misoprostol Misoprostol, (11alpha,13E)-Isomer Misoprostol, (11alpha.13E,16S)-Isomer Novo-Misoprostol Misoprostol, (11beta,13E)-(+-)-Isomer SC 29333 Misoprostol, (11alpha,13Z)-(+-)-Isomer SC 30249 SC30249 SC-29333 Cytotec Misoprostol, (11alpha,13E,16R)-Isomer Misoprostol, (11beta,13E,16R)-Isomer |
|
AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
cui |
C1563870 C0591321 C0886819 C1563872 C0886820 C0886816 C0886817 C0886818 C0524774 C0886815 C0085174 C1563871 C0886814 C0795730 |
|
DC |
1 |
|
definition |
A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties. |
|
DX |
19920101 |
|
HN |
92; was MISOPROSTOL (NM) 1977-91 |
|
Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
Inverse of RB |
59122-48-4 58717-36-5 59122-51-9 59122-50-8 0E43V0BB57 58717-37-6 59122-49-5 92999-98-9 0 |
|
isa |
http://purl.bioontology.org/ontology/MESH/D000897 |
|
LT |
TRD |
|
Machine permutation |
92; MISOPROSTOL was indexed under ALPROSTADIL/analogs & derivatives 1986-91, under PROSTAGLANDINS E, SYNTHETIC 1979-85 & under PROSTAGLANDINS, SYNTHETIC 1977-78 |
|
Mapped from |
http://purl.bioontology.org/ontology/MESH/C475855 |
|
MDA |
19910125 |
|
MMR |
20160701 |
|
MN |
D23.469.050.175.725.775.450.500 D23.469.700.660.500 D10.251.355.255.550.775.450.500 |
|
notation |
D016595 |
|
OL |
use MISOPROSTOL (NM) to search MISOPROSTOL 1980-91 |
|
PA |
D010120 D000897 D000020 |
|
prefLabel |
Misoprostol |
|
RR |
59122-50-8 ((11beta,13E,16S)-isomer) 59122-48-4 ((11alpha,13E,16R)-isomer) 92999-98-9 ((11alpha,13E)-isomer) 59122-49-5 ((11alpha.13E,16S)-isomer) 58717-36-5 ((11beta,13E)-(+-)-isomer) 59122-51-9 ((11beta,13E,16R)-isomer) 59122-46-2 (Misoprostol) 58717-37-6 ((11alpha,13Z)-(+-)-isomer) |
|
TERMUI |
T614546 T614550 T359664 T049700 T359660 T049703 T359665 T049702 T359661 T049701 T359663 T359662 T359659 T614548 |
|
TH |
US MX POPLINE (1994) UK NL NLM (1999) USAN (1981) CA FDA SRS (2014) JAN (19XX) ES NLM (1992) INN (19XX) DE AU NLM (1998) USP (19XX) BAN (19XX) FR IE |
|
tui |
T109 T121 |
|
subClassOf |